Drug Patents owned by Javelin Pharms Inc

1. Drug name - DYLOJECT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8946292 JAVELIN PHARMS INC Formulations of low dose diclofenac and beta-cyclodextrin Mar, 2027

(4 years from now)

Drugs and Companies using DICLOFENAC SODIUM ingredient

Treatment: Management of pain

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
37.5MG/ML (37.5MG/ML) SOLUTION;INTRAVENOUS Discontinued

availability in other generic markets.

Click on the highlighted region to filter.